- Home
- CRDL vs MGYR Comparison
CRDL vs MGYR Comparison
Compare CRDL & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- MGYR
- Stock Information
- Founded
- CRDL 2017
- MGYR 1922
- Country
- CRDL Canada
- MGYR United States
- Employees
- CRDL N/A
- MGYR N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- MGYR Savings Institutions
- Sector
- CRDL Health Care
- MGYR Finance
- Exchange
- CRDL Nasdaq
- MGYR Nasdaq
- Market Cap
- CRDL 90.4M
- MGYR 107.3M
- IPO Year
- CRDL N/A
- MGYR 2006
- Fundamental
- Price
- CRDL $1.22
- MGYR $16.75
- Analyst Decision
- CRDL Strong Buy
- MGYR
- Analyst Count
- CRDL 2
- MGYR 0
- Target Price
- CRDL $9.00
- MGYR N/A
- AVG Volume (30 Days)
- CRDL 859.1K
- MGYR 1.9K
- Earning Date
- CRDL 11-13-2025
- MGYR 10-30-2025
- Dividend Yield
- CRDL N/A
- MGYR 2.15%
- EPS Growth
- CRDL N/A
- MGYR 35.01
- EPS
- CRDL N/A
- MGYR 1.57
- Revenue
- CRDL N/A
- MGYR $35,533,000.00
- Revenue This Year
- CRDL N/A
- MGYR N/A
- Revenue Next Year
- CRDL N/A
- MGYR N/A
- P/E Ratio
- CRDL N/A
- MGYR $10.69
- Revenue Growth
- CRDL N/A
- MGYR 18.29
- 52 Week Low
- CRDL $0.77
- MGYR $12.10
- 52 Week High
- CRDL $2.24
- MGYR $19.04
- Technical
- Relative Strength Index (RSI)
- CRDL 63.48
- MGYR 38.53
- Support Level
- CRDL $1.01
- MGYR $16.75
- Resistance Level
- CRDL $1.38
- MGYR $17.00
- Average True Range (ATR)
- CRDL 0.08
- MGYR 0.08
- MACD
- CRDL 0.02
- MGYR -0.04
- Stochastic Oscillator
- CRDL 58.60
- MGYR 0.00
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.